Literature DB >> 33271808

Comparable Vδ2 Cell Functional Characteristics in Virally Suppressed People Living with HIV and Uninfected Individuals.

Matthew L Clohosey1, Brendan T Mann2, Paul L Ryan3, Tatiyana V Apanasovich4, Sanjay B Maggirwar2, Daniel J Pennington5, Natalia Soriano-Sarabia2.   

Abstract

Crosstalk between innate and adaptive pathways is a critical component to developing an effective, lasting immune response. Among natural effector cells, innate-like γδ T cells promote immunity by facilitating communication between the two compartments and exerting cytotoxic effector functions. Dysregulation of γδ T cell populations is a byproduct of primary Humanimmunodeficiency virus (HIV) infection. This is most pronounced in the depletion and loss of function within cells expressing a Vγ9Vδ2 TCR (Vδ2 cells). Whether or not prolonged viral suppression mediated by antiretroviral therapy (ART) can reverse these effects has yet to be determined. In this study, we present evidence of similar Vδ2 cell functional responses within a cohort of people living with HIV (PLWH) that has been stably suppressed for >1 year and uninfected donors. Through the use of aminobisphosphonate drugs, we were able to generate a comprehensive comparison between ex vivo and expanded Vδ2 cells within each group. Both groups had largely similar compositions of memory and effector phenotypes, post-expansion TCR repertoire diversity, and cytotoxic capabilities. Our findings support the notion that ART promotes the recovery of Vδ2 polyfunctionality and provides insight for strategies aiming to reconstitute the full immune response after infection with HIV.

Entities:  

Keywords:  HIV; TCR; antiretroviral therapy; cytotoxicity; gammadelta T cells

Mesh:

Substances:

Year:  2020        PMID: 33271808      PMCID: PMC7760715          DOI: 10.3390/cells9122568

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   7.666


  42 in total

1.  Gamma/delta T-cell stimulation by pamidronate.

Authors:  V Kunzmann; E Bauer; M Wilhelm
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

2.  Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli.

Authors:  M Hintz; A Reichenberg; B Altincicek; U Bahr; R M Gschwind; A K Kollas; E Beck; J Wiesner; M Eberl; H Jomaa
Journal:  FEBS Lett       Date:  2001-12-07       Impact factor: 4.124

3.  Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites.

Authors:  Giulia Costa; Séverine Loizon; Marianne Guenot; Iulia Mocan; Franck Halary; Geneviève de Saint-Basile; Vincent Pitard; Julie Déchanet-Merville; Jean-François Moreau; Marita Troye-Blomberg; Odile Mercereau-Puijalon; Charlotte Behr
Journal:  Blood       Date:  2011-11-01       Impact factor: 22.113

Review 4.  γδ T cell receptor ligands and modes of antigen recognition.

Authors:  Eric Champagne
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-02-06       Impact factor: 4.291

Review 5.  Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies.

Authors:  Zsolt Sebestyen; Immo Prinz; Julie Déchanet-Merville; Bruno Silva-Santos; Jurgen Kuball
Journal:  Nat Rev Drug Discov       Date:  2019-09-06       Impact factor: 84.694

6.  Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells.

Authors:  Nadia Caccamo; Francesco Dieli; Daniela Wesch; Hassan Jomaa; Matthias Eberl
Journal:  J Leukoc Biol       Date:  2006-02-03       Impact factor: 4.962

Review 7.  γδ T Cells in HIV Disease: Past, Present, and Future.

Authors:  C David Pauza; Bhawna Poonia; Haishan Li; Cristiana Cairo; Suchita Chaudhry
Journal:  Front Immunol       Date:  2015-01-30       Impact factor: 7.561

8.  Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging.

Authors:  Anna C Belkina; Alina Starchenko; Katherine A Drake; Elizabeth A Proctor; Riley M F Pihl; Alex Olson; Douglas A Lauffenburger; Nina Lin; Jennifer E Snyder-Cappione
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 8.786

9.  Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells.

Authors:  Hans-Jürgen Gober; Magdalena Kistowska; Lena Angman; Paul Jenö; Lucia Mori; Gennaro De Libero
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

10.  Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection.

Authors:  Nupur Bhatnagar; Pierre-Marie Girard; Moises Lopez-Gonzalez; Céline Didier; Lio Collias; Corinne Jung; Diane Bollens; Claudine Duvivier; Cassandre Von Platen; Daniel Scott-Algara; Laurence Weiss
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

View more
  2 in total

Review 1.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

2.  Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran.

Authors:  Dieter Kabelitz
Journal:  Cells       Date:  2020-11-30       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.